The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease
Abstract
A considerable body of evidence exists suggesting that androgen deficiency contributes to the onset, progression, or both of cardiovascular disease (CVD). The aim of this review is to evaluate the relationships between testosterone (T) deficiency and risk factors of CVD and to discuss the implications of androgen deficiency in men with cardiovascular risk factors. The relationship between androgen deficiency and endothelial function, lipid profiles, inflammatory responses, altered vascular smooth muscle reactivity, and hypertension are discussed with regard to CVD. A comprehensive literature search was carried out with the use of Pub Med from 1980 through 2009, and relevant articles pertinent to androgen deficiency and vascular disease were evaluated and discussed. Low T, whether attributed to hypogonadism or androgen deprivation therapy, in men with prostate carcinoma, produces adverse effects on cardiovascular health. Androgen deficiency is associated with increased levels of total cholesterol, low‐density lipoprotein, increased production of proinflammatory factors, and increased thickness of the arterial wall and contributes to endothelial dysfunction. Testosterone supplementation restores arterial vasoreactivity; reduces proinflammatory cytokines, total cholesterol, and triglyceride levels; and improves endothelial function but also might reduce high‐density lipoprotein levels. Testosterone is an anabolic hormone with a wide range of beneficial effects on men's health. The therapeutic role of T in men's health, however, remains a hotly debated issue for a number of reasons, including the purported risk of prostate cancer. In view of the emerging evidence suggesting that androgen deficiency is a risk factor for CVD, androgen replacement therapy could potentially reduce CVD risk in hypogonadal men. It should be emphasized, however, that androgen replacement therapy should be done with very thorough and careful monitoring for prostate diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kim, J.-A., Montagnani, M., Koh, K. K., & Quon, M. J. (2006) · Circulation · doi:10.1161/circulationaha.105.563213 · Cited by 1,652
Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer
Keating, N. L., O'Malley, A. J., & Smith, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.2497 · Cited by 1,455
Reaven, G. M., Lithell, H., & Landsberg, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199602083340607 · Cited by 1,435
Low Serum Testosterone and Mortality in Older Men
Laughlin, G. A., Barrett-Connor, E., & Bergstrom, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1792 · Cited by 798
Kapoor, D., Goodwin, E., Channer, K. S., & Jones, T. H. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02166 · Cited by 791
Effects of testosterone supplementation in the aging male
Tenover, J. S. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.4.1092 · Cited by 768
Khaw, K.-T., Dowsett, M., Folkerd, E., Bingham, S., Wareham, N., Luben, R., Welch, A., & Day, N. (2007) · Circulation · doi:10.1161/circulationaha.107.719005 · Cited by 743
Malkin, C. J., Pugh, P. J., Jones, R. D., Kapoor, D., Channer, K. S., & Jones, T. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031069 · Cited by 731
Changes in body composition during androgen deprivation therapy for prostate cancer
Smith, M. R., Finkelstein, J. S., McGovern, F. J., Zietman, A. L., Fallon, M. A., Schoenfeld, D. A., & Kantoff, P. W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8299 · Cited by 697
Oh, J.-Y., Barrett-Connor, E., Wedick, N. M., & Wingard, D. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.1.55 · Cited by 594
Research works printed but not linked: 133
- 10.1111/j.1365-2362.2004.01339.x · DOI
- 10.1016/8756-3282(95)00441-6 · DOI
- 10.1001/archinte.167.12.1252 · DOI · Paper page
- 10.1210/jc.79.2.561 · DOI · Paper page
- 10.1016/j.jacc.2005.02.057 · doi:10.1016/j.jacc.2005.02.057
- 10.1161/01.CIR.78.3.539 · DOI · Paper page
- 10.1016/S0021-9150(02)00069-2 · DOI
- 10.2164/jandrol.108.005454 · DOI
- 10.1016/S0002-9343(01)00663-5 · DOI
- 10.1161/CIRCULATIONAHA.107.740365 · DOI
- 10.1002/cncr.21642 · DOI · Paper page
- 10.1091/mbc.10.10.3113 · DOI · Paper page
- 10.1007/s00210-007-0213-3 · DOI
- 10.2337/diab.47.2.290 · DOI
- 10.1681/ASN.2008060664 · DOI · Paper page
- 10.1111/j.1442-2042.2005.01145.x · DOI
- 10.1161/01.CIR.94.10.2614 · DOI · Paper page
- 10.1046/j.1440-1681.1999.03110.x · DOI
- 10.1038/sj.ijo.0802292 · DOI
- Dobrzycki S., 2003, An assessment of correlations between endogenous sex hormone levels and the extensiveness of coronary heart disease and the ejection fraction of the left ventricle in males, J Med Invest, 50, 162
- 10.1210/jc.86.3.1026 · DOI
- Dockery F., 2003, Testosterone suppression in men with prostate cancer leads to an increase in arterial stiffness and hyperinsulinaemia, Clin Sci, 104, 195, 10.1042/cs1040195 · DOI · Paper page
- 10.1016/S0008-6363(01)00527-2 · DOI · Paper page
- 10.1080/13685530400004181 · DOI
- 10.1007/BF03344037 · DOI
- 10.1016/j.ceca.2006.09.003 · DOI
- 10.1038/sj.ijir.3901447 · DOI · Paper page
- 10.1016/j.amjcard.2005.07.005 · DOI
- 10.1210/jc.2006-0763 · DOI
- Foresta C., 2008, Androgens stimulate endothelial progenitor cells through an androgen‐mediated pathway, Clin Endo, 68, 284, 10.1111/j.1365-2265.2007.03036.x · DOI
- 10.1111/j.1745-7262.2008.00335.x · DOI
- 10.1016/0960-0760(94)90025-6 · DOI
- 10.2337/diacare.26.6.1869 · DOI
- 10.1152/ajpheart.2000.279.2.H610 · DOI
- 10.1161/01.ATV.19.8.1925 · DOI
- 10.1172/JCI10762 · DOI · Paper page
- 10.1053/meta.2001.24916 · DOI
- 10.2337/diab.43.2.212 · DOI · Paper page
- 10.1038/sj.ijo.0801279 · DOI · Paper page
- 10.1016/S0002-9149(00)00784-0 · DOI
- 10.1210/jc.77.6.1610 · DOI · Paper page
- 10.1080/13685530701653538 · DOI
- 10.1210/jcem.87.8.8762 · doi:10.1210/jcem.87.8.8762 · Paper page
- 10.1111/j.1464-410X.2008.07933.x · DOI
- 10.1210/en.2005-1243 · DOI
- 10.1253/circj.CJ-08-1102 · DOI · Paper page
- 10.1046/j.1365-2265.2001.01297.x · DOI
- 10.1097/01.fjc.0000175434.64412.9d · DOI
- Isidori AM, 2005, Androgens, cardiovascular disease and osteoporosis, J Endocrinol Invest, 28, 73
- 10.1111/j.1742-1241.2006.01112.x · DOI
- 10.1161/01.ATV.16.6.749 · DOI
- 10.1042/CS20030386 · DOI
- 10.1530/eje.0.1510029 · DOI
- 10.1210/jc.2002-021738 · DOI
- 10.2165/00129784-200505030-00001 · DOI
- 10.1038/ijir.2008.36 · DOI
- 10.1038/sj.bjp.0706936 · DOI
- 10.1046/j.1439-0272.2002.00468.x · doi:10.1046/j.1439-0272.2002.00468.x
- 10.1093/oxfordjournals.aje.a114704 · DOI
- 10.1074/jbc.M200491200 · DOI · Paper page
- 10.1016/j.steroids.2004.02.004 · DOI
- 10.1210/er.2003-0005 · DOI · Paper page
- 10.1111/j.1745-7262.2007.00327.x · DOI
- 10.1001/jama.300.2.173 · DOI · Paper page
- Ly LP, 2001, A double‐blind, placebo‐controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen deficiency, J Clin Endocrinol Metab, 86, 4078, 10.1210/jcem.86.9.7821 · doi:10.1210/jcem.86.9.7821 · Paper page
- 10.1001/archinte.167.20.2249 · DOI · Paper page
- 10.1097/01.ju.0000169490.78443.59 · DOI · Paper page
- 10.1016/j.jacc.2005.01.052 · DOI · Paper page
- 10.1016/j.atherosclerosis.2007.05.009 · DOI
- 10.1016/j.amjcard.2003.07.044 · DOI
- 10.1677/joe.0.1780373 · DOI · Paper page
- 10.1093/qjmed/hcg086 · DOI
- 10.1093/eurheartj/ehi443 · DOI · Paper page
- 10.1210/jc.81.3.1018 · doi:10.1210/jc.81.3.1018 · Paper page
- 10.1007/s11892-003-0059-0 · DOI
- 10.1016/j.tips.2007.04.004 · DOI
- 10.1006/jmcc.1998.0844 · DOI · Paper page
- Montagnana M., 2008, Relationship between serum testosterone and cardiovascular risk profile in the general population, Arch Intern Med, 23, 168
- 10.1210/en.2007-1288 · DOI
- 10.1210/jc.2004-1158 · DOI · Paper page
- 10.1161/01.CIR.0000125854.51637.06 · DOI · Paper page
- Murphy JG, 1999, Decreased [Ca(2+)](i) during inhibition of coronary smooth muscle contraction by 17beta‐estradiol, progesterone, and testosterone, J Pharmacol Exp Ther, 291, 44, 10.1016/S0022-3565(24)35069-4 · DOI
- 10.1016/0021-9150(81)90070-8 · DOI
- 10.1016/j.lfs.2008.08.009 · DOI
- 10.1016/S1098-3597(08)80003-8 · DOI
- 10.1210/jc.2004-1611 · DOI
- 10.1016/j.lfs.2007.07.024 · DOI
- 10.1095/biolreprod.104.036954 · DOI
- 10.1161/01.ATV.14.5.701 · DOI · Paper page
- 10.1210/jc.2004-2190 · DOI · Paper page
- 10.1373/clinchem.2008.104901 · DOI · Paper page
- 10.7326/0003-4819-118-6-199303150-00006 · DOI · Paper page
- Prehn RT, 1999, On the prevention and therapy of prostate cancer by androgen administration, Cancer Res, 59, 4161
- 10.1016/S0195-668X(03)00083-6 · DOI · Paper page
- 10.1093/jnci/djm323 · DOI · Paper page
- 10.1046/j.1365-2265.2003.01796.x · DOI
- 10.1046/j.1365-2265.2001.01176.x · DOI
- 10.1016/j.ceca.2006.11.003 · DOI
- 10.1016/j.bbrc.2004.04.054 · DOI · Paper page
- 10.1254/jphs.FP0060883 · DOI
- 10.1210/jc.2007-2595 · DOI · Paper page
- 10.1001/archinte.166.15.1660 · DOI · Paper page
- Shores MM, Low serum testosterone and mortality in male veterans, Arch Int Med, 166, 1660, 10.1001/archinte.166.15.1660 · DOI · Paper page
- 10.1016/j.steroids.2004.05.009 · DOI · Paper page
- 10.1161/CIRCULATIONAHA.104.489088 · DOI · Paper page
- 10.1097/MED.0b013e32814db88c · DOI
- 10.1158/1078-0432.CCR-06-2086 · DOI
- 10.1007/s11934-008-0035-y · DOI
- 10.1210/jcem.86.9.7851 · DOI · Paper page
- 10.1016/S0002-9149(99)00357-4 · DOI
- Sochorová R., 1991, The possible influence of testosterone on calcium ion transport (investigated) in guinea pig uterus, Acta Physiol Hung, 77, 19
- 10.1002/ijc.11572 · DOI · Paper page
- 10.1038/sj.ijir.3901499 · DOI
- 10.1530/eje.0.1500065 · DOI · Paper page
- 10.1080/713604792 · DOI
- 10.1046/j.1365-2265.1998.00372.x · DOI
- 10.1016/S0014-2999(03)01453-5 · DOI
- 10.1001/jama.1989.03420080085036 · DOI · Paper page
- 10.2337/dc07-1231 · DOI · Paper page
- 10.2174/138161208786898699 · DOI
- 10.2164/jandrol.108.005215 · DOI · Paper page
- 10.1002/ijc.22814 · DOI
- 10.1016/S0021-9150(02)00308-8 · DOI
- 10.1016/j.amjcard.2007.09.114 · DOI
- 10.1016/S0002-9149(98)00880-7 · DOI · Paper page
- 10.1210/er.2001-0025 · DOI · Paper page
- 10.1016/j.juro.2006.03.057 · DOI
- 10.1055/s-2007-949657 · doi:10.1055/s-2007-949657
- 10.1097/01.fjc.0000161400.06704.1e · DOI
- 10.1161/01.CIR.91.4.1154 · DOI · Paper page
- 10.2174/187152906776092659 · DOI · Paper page
- 10.1016/0021-9150(95)05673-4 · DOI · Paper page
- 10.1093/oxfordjournals.aje.a009326 · DOI · Paper page
Cited by
Xu, L., Freeman, G., Cowling, B. J., & Schooling, C. M. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-108 · Cited by 563
Haugnes, H. S., Wethal, T., Aass, N., Dahl, O., Klepp, O., Langberg, C. W., Wilsgaard, T., Bremnes, R. M., & Fosså, S. D. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.9362 · Cited by 404
The role of androgens and estrogens on healthy aging and longevity
Horstman, A. M., Dillon, E. L., Urban, R. J., & Sheffield-Moore, M. (2012) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/gls068 · Cited by 396
Update: Hypogonadotropic Hypogonadism in Type 2 Diabetes and Obesity
Dandona, P., & Dhindsa, S. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2724 · Cited by 313
Juster, R.-P., Bizik, G., Picard, M., Arsenault-Lapierre, G., Sindi, S., Trepanier, L., Marin, M.-F., Wan, N., Sekerovic, Z., Lord, C., et al. (2011) · Development and Psychopathology · doi:10.1017/s0954579411000289 · Cited by 268
Metadata
- Authors
- Traish, A. M., Saad, F., Feeley, R. J., & Guay, A.
- Venue
- Journal of Andrology
- Publisher
- Wiley
- Published
- 2009-09-10
- Volume
- 30
- Issue
- 5
- Pages
- 477-494
- ISSN
- 0196-3635 (ISSN-L)
- 1939-4640
- OpenAlex
- W2053748857
- Cited by
- 239
- References
- 39
- FWCI
- 19.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease. https://app.cochat.ai/papers/10.2164/jandrol.108.007245
- The paper
- Traish, A. M., Saad, F., Feeley, R. J., & Guay, A. (2009). The Dark Side of Testosterone Deficiency: III. Cardiovascular Disease. Journal of Andrology. https://doi.org/10.2164/jandrol.108.007245
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.